CorVel Corp header image

CorVel Corp

CRVL

Equity

ISIN null / Valor 921843

NASDAQ (2026-06-04)
USD 59.22+3.40%

CorVel Corp
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

CorVel Corporation is a publicly traded provider of technology-driven workers’ compensation and disability management services, combining claims administration, medical bill review and payment, provider network access, telemedicine and utilization-review services with analytics and case management tools to help insurers, third-party administrators, self-insured employers and government entities manage workplace injury and absence costs. Headquartered in Irvine, California, the company operates a nationwide network of medical providers and pharmacy services and markets a proprietary claims and healthcare management platform that automates workflows, controls medical spend and supports return-to-work programs, generating revenue from service fees, technology subscriptions and managed-care arrangements.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results (14.05.2026):

CorVel Corp’s third quarter of fiscal 2026 (quarter ended December 31, 2025) showed modest top-line growth and slight EPS improvement: revenue was $235.6 million (reported as $236 million), up 3% year-over-year, and diluted EPS was $0.47, up 2% from $0.46 a year ago. Year-to-date (nine months) results were stronger—revenues of $710.0 million, up 7%, and diluted EPS of $1.53, up 16% versus the prior-year period—while gross profit and operating income also increased.

Quarter snapshot

Q3 FY2026 revenue of $235.6M vs. $227.97M a year earlier; gross profit $54.92M (23% margin) vs. $52.86M; income from operations $32.23M; net income $24.17M; diluted EPS $0.47 vs. $0.46 in Q3 FY2025.

Nine‑month / YTD performance

For the nine months ended Dec 31, 2025, revenues were $709.98M (up 7% vs. $664.08M), gross profit $169.85M, income from operations $103.42M, net income $79.32M, and diluted EPS $1.53 (up 16% vs. $1.32).

Profitability & margins

Gross profit rose 4% in the quarter to $54.9M with a 23% gross margin; operating income and net income both increased modestly year‑over‑year, supporting the EPS gain despite a slightly higher tax provision ($8.06M vs. $7.03M).

Balance sheet & capital returns

CorVel exited the quarter with $230.0M of cash and cash equivalents and no borrowings; customer deposits and accrued liabilities increased. The company repurchased $13.4M of common stock during the quarter.

Operational & strategic progress

Management reports material advancement of AI initiatives—using AI and agentic AI to boost development velocity, operational efficiency, and product/service outcomes—and says integration of a recent strategic acquisition is progressing ahead of plan, supporting product and technology expansion.

Summarized from source with an LLMView Source

Key figures

-46.8%1Y
-71.0%3Y
-50.3%5Y

Performance

41.9%1Y
73.1%3Y
59.9%5Y

Volatility

Market cap

3002 M

Market cap (USD)

Daily traded volume (Shares)

409,834

Daily traded volume (Shares)

1 day high/low

113.15 / 111.5

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Option Care Health Inc
Option Care Health Inc Option Care Health Inc Valor: 52359365
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.24%USD 20.07
Alkermes PLC
Alkermes PLC Alkermes PLC Valor: 13920929
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.45%USD 43.38
Denali Therapeutics Inc
Denali Therapeutics Inc Denali Therapeutics Inc Valor: 39149539
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.44%USD 20.14
RHOEN-KLINIKUM AG
RHOEN-KLINIKUM AG RHOEN-KLINIKUM AG Valor: 341644
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.81%EUR 12.40
Illumina Inc
Illumina Inc Illumina Inc Valor: 1111080
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.68%USD 168.06
Galapagos NV
Galapagos NV Galapagos NV Valor: 2130343
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.33%EUR 24.40
Straumann Holding Ltd
Straumann Holding Ltd Straumann Holding Ltd Valor: 117544866
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.68%CHF 93.98
Teva Pharmaceutical Industries Ltd
Teva Pharmaceutical Industries Ltd Teva Pharmaceutical Industries Ltd Valor: 758744
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
4.87%USD 34.43
Fresenius Medical Care AG
Fresenius Medical Care AG Fresenius Medical Care AG Valor: 523134
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
4.93%USD 21.93
Orion Oyj
Orion Oyj Orion Oyj Valor: 2553360
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.60%EUR 70.00